About Enable Injections
Enable Injections is a company based in Cincinnati (United States) founded in 2010 by Mike Hooven. Enable Injections has raised $334.27 million across 11 funding rounds from investors including Cincinnati Children’s, Grosvenor Capital Management and Sanofi. The company has 185 employees as of December 31, 2023. Enable Injections offers products and services including enFuse Wearable, enFuse Transfer Systems, enFuse Smart Technology, and Empaveli. Enable Injections operates in a competitive market with competitors including Micron Biomedical, Zosano Pharma, Raphas, SkinJect and STM, among others.
- Headquarter Cincinnati, United States
- Employees 185 as on 31 Dec, 2023
- Founders Mike Hooven
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Enable Injections
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$334.27 M (USD)
in 11 rounds
-
Latest Funding Round
$30 M (USD), Series C
Jan 06, 2026
-
Investors
Cincinnati Children’s
& 11 more
-
Employee Count
185
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enable Injections
Enable Injections offers a comprehensive portfolio of products and services, including enFuse Wearable, enFuse Transfer Systems, enFuse Smart Technology, and Empaveli.
Wearable device for hands-free subcutaneous medication delivery.
Systems for transferring medications in wearable formats.
Intelligent features for monitoring and administering drugs.
Wearable injector for specific drug therapies.
People of Enable Injections
Unlock access to complete
Unlock access to complete
Funding Insights of Enable Injections
Enable Injections has successfully raised a total of $334.27M across 11 strategic funding rounds. The most recent funding activity was a Series C round of $30 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Enable Injections
Enable Injections has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Cincinnati Children’s, Grosvenor Capital Management and Sanofi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Magnetar Capital is engaged in alternative asset management.
|
Locked | Locked | Locked | |
|
Private fund focused on debt and equity investments in real estate and multiple sectors
|
Locked | Locked | Locked | |
|
Early-stage sector-agnostic VC firm investing in geographies such as the US
|
Locked | Locked | Locked |
Investor details for Enable Injections
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enable Injections
Investment portfolio details for Enable Injections
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Enable Injections
Detailed financials for Enable Injections
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enable Injections Comparisons
Peer comparison for Enable Injections
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Enable Injections
Enable Injections operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Micron Biomedical, Zosano Pharma, Raphas, SkinJect and STM, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microneedle patches are developed for vaccine and drug delivery.
|
|
| Locked | Locked | Locked |
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
|
|
| Locked | Locked | Locked |
Microneedle technology is developed for cosmetics and medical applications.
|
|
| Locked | Locked | Locked |
Dissolvable microneedle patches for non-melanoma skin cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Transdermal patches for painless vaccine delivery via microneedles are developed.
|
Detailed competitors of Enable Injections
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enable Injections
Complete news archive for Enable Injections
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enable Injections
Enable Injections was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Enable Injections is headquartered in Cincinnati, United States. It is registered at Cincinnati, Ohio, United States.
Mike Hooven is the current CEO of Enable Injections. They have also founded this company.
Enable Injections is a funded company, having raised a total of $334.27M across 11 funding rounds to date.
As of Dec 31, 2023, the latest employee count at Enable Injections is 185.
Provider of a wearable drug delivery solution. The companys drug delivery device include enFuse for injectable therapies which enables a range of flexible delivery options for patients and healthcare providers, including a range of viscosities, volumes, delivery times, and sites for administration.
Enable Injections's top competitors include Micron Biomedical, SkinJect and Raphas.
Enable Injections offers enFuse Wearable, enFuse Transfer Systems, enFuse Smart Technology, and Empaveli.
Enable Injections has 12 investors. Key investors include Cincinnati Children’s, Grosvenor Capital Management, Sanofi, Barings, and Oxford Finance.